1. Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country
- Author
-
Muntañola, Ana, Villacampa, Guillermo, Hernández-Rivas, José Ángel, Alonso, Rosalía, Mirás, Fátima, Osorio, Santiago, Baile, Mónica, Baltasar, Patricia, López Jiménez, Javier, Hernández‑Rodríguez, Inés, Valenciano, Susana, Alfayate, Ana, Gimeno, Eva, Bárez, Abelardo, Oliveira, Ana Carla, Riaza Grau, Rosalía, Romero, Pilar, Delgado, Julio, Yáñez, Lucrecia, Zabalza, Amaya, Torres, Ana, Gómez-Roncero, María Isabel, Crespo, Marta, Córdoba, Raúl, Mateos, Juan José, Pérez, Sonia, Andreu, Rafael, Labrador, Jorge, Ruiz, María Elena, Velasquez, César Andrés, Terol, María José, Santiago, Raquel, Vidal, María Jesús, Campoy García, Fiz, Villalón, Lucía, Muiña, Begoña, Soler, Joan Alfons, Seri, Cristina, Sánchez, María José, Cuesta, Amalia, Ramos, Rafael, Sánchez‑Montalvá, Sánchez‑Montalvá, Adrán, Ruiz‑Camps, Isabel, González, Marcos, Abrisqueta, Pau, Bosch, Francesc, Abrisqueta, Pau [0000-0001-9625-7422], and Abrisqueta, Pau
- Subjects
Cancer Research ,2019-20 coronavirus outbreak ,medicine.medical_specialty ,Leucèmia limfoide ,Hematology ,Coronavirus disease 2019 (COVID-19) ,business.industry ,lcsh:RC633-647.5 ,Chronic lymphocytic leukemia ,Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ,MEDLINE ,lcsh:Diseases of the blood and blood-forming organs ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,COVID-19 (Malaltia) ,lcsh:RC254-282 ,Oncology ,Internal medicine ,medicine ,business ,Letter to the Editor - Abstract
Spain has been one the most affected countries by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of coronavirus disease 2019 (COVID-19) pandemic [1, 2]. Patients with chronic lymphocytic leukemia (CLL) could be at risk of more severe COVID-19 clinical forms [3] since they often carry immune perturbations aggravated by treatments used for the disease itself [4]. Two major series on patients with COVID-19 and CLL encompassing different countries and health systems reported heterogeneous factors related to the outcome [5, 6]. Herein, we are presenting the largest series of CLL patients with proved COVID-19 from a single country and Health system.
- Published
- 2020